BLUE FIN GROUP

Blue Fin Group is a management and consulting company for the pharmaceutical and biotech industry. It delivers research, strategy, and implementation to help manufacturers align all the elements of marketing, market access, field sales, pharmacy and distribution, and patient services as a seamless commercial strategy that helps optimize patient outcomes. The team of highly experienced consultants and access professionals has served more than 300 manufacturers–primarily those commercializing their first asset or large global firms with products that span cell and gene therapies, orphan/rare, specialty, primary care, vaccines, biosimilars, and generics. It was founded in 2001 and is based in New York, New York.